scholarly journals Retrospective Evaluation of Primary Mediastinal Large B Cell Lymphoma Treatment Results

LLM Dergi ◽  
2018 ◽  
Vol 2 (3) ◽  
pp. 60-64
Author(s):  
Erden ATİLLA ◽  
Pınar ATACA ATİLLA ◽  
Güldane CENGİZ SEVAL ◽  
Selami Koçak TOPRAK ◽  
Osman İLHAN ◽  
...  
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Retrospective Evaluation ◽  
Treatment Results ◽  
Large B Cell Lymphoma ◽  
Lymphoma Treatment ◽  
Large B Cell

Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure

2018 ◽  
Vol 59 (12) ◽  
pp. 2896-2903 ◽  
Author(s):  
Ethan B. Ludmir ◽  
Sarah A. Milgrom ◽  
Chelsea C. Pinnix ◽  
Jillian R. Gunther ◽  
Jason Westin ◽  
...  
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
Treatment Strategies ◽  
B Cell Lymphoma ◽  
Patterns Of Failure ◽  
Large B Cell Lymphoma ◽  
Lymphoma Treatment ◽  
Large B Cell

Retrospective evaluation of patients with primary mediastinal large B-Cell lymphoma: Real life experience

2021 ◽  
Vol 28 (10) ◽  
pp. 1830
Author(s):  
Zeynep Guven ◽  
Serhat Celik ◽  
Leylagul Kaynar ◽  
Muzaffer Keklik ◽  
Bulent Eser ◽  
...  
Keyword(s):  
B Cell ◽  
Life Experience ◽  
Cell Lymphoma ◽  
Real Life ◽  
B Cell Lymphoma ◽  
Retrospective Evaluation ◽  
Large B Cell Lymphoma ◽  
Large B Cell

Clinical Features and Treatment Results of Children with Diffuse Large B-Cell Lymphoma

2014 ◽  
Vol 31 (6) ◽  
pp. 509-517 ◽  
Author(s):  
Erman Ataş ◽  
M. Tezer Kutluk ◽  
Canan Akyüz ◽  
Gülsev Kale ◽  
Ali Varan ◽  
...  
Keyword(s):  
B Cell ◽  
Clinical Features ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Treatment Results ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Prognostic Factors in Elderly Patients With Diffuse Large B-Cell Lymphoma and Their Treatment Results

2019 ◽  
Author(s):  
Süleyman Cem Adıyaman ◽  
İnci Alacacioğlu ◽  
Ayça Ersen Danyeli ◽  
Doğuş Türkyılmaz ◽  
Ömür Gökmen Sevindik ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Elderly Patients ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Treatment Results ◽  
Large B Cell Lymphoma ◽  
Large B Cell

Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOP

Hematology ◽  
2013 ◽  
Vol 2013 (1) ◽  
pp. 591-595 ◽  
Author(s):  
Leandro Cerchietti ◽  
John P. Leonard
Keyword(s):  
Clinical Trials ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Prognostic Information ◽  
Large B Cell Lymphoma ◽  
Lymphoma Treatment ◽  
Histone Modifiers ◽  
Novel Therapeutic Strategies ◽  
Large B Cell

Abstract Diffuse large B-cell lymphoma, the most common lymphoma subtype, is curable in the majority of patients. However, one of the greatest unmet needs in lymphoma treatment remains novel approaches to prevent relapsed or refractory disease. Genomic profiling has provided important prognostic information that is being used in the development of novel therapeutic strategies currently in clinical trials. It is clear, however, that epigenetic alterations provide an additional series of targets that can be pharmacologically modified and offer great potential to improving patient outcomes. Greater understanding of this area is providing important new insights that are now being explored in the clinical setting. Demethylating agents and drugs that disrupt histone modifiers are in early clinical trials with promising results, and other approaches targeting epigenetic pathways are in active preclinical and early clinical development.

Sign in / Sign up

Export Citation Format

Share Document